| 1 | Differentiation of MPNSTs from benign neurofibromas in neurofibromatosis patients using ADC and SUV biomarkers in children and young adults. (Shokri Varniab Z, Lokesha YU, Qi J, Wong J, Iv M, Hawk E, Daldrup-Link H) Curr Probl Diagn Radiol 2026;55(6):811-818 |
| 1 | Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis. (Klein-Tasman BP, Lee K, Thompson HL, Janusz J, Payne JM, Pardej S, de Blank P, Kennedy T, Janke KM, Castillo AD, Walsh KS, REiNS International Collaboration) Neurology 2021 Aug 17;97(7 Suppl 1):S81-S90 4 Citations |
| 1 | Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. (Janusz JA, Klein-Tasman BP, Payne JM, Wolters PL, Thompson HL, Martin S, de Blank P, Ullrich N, Del Castillo A, Hussey M, Hardy KK, Haebich K, Rosser T, Toledo-Tamula MA, Walsh KS, REiNS International Collaboration) Neurology 2021 Aug 17;97(7 Suppl 1):S73-S80 5 Citations |
| 1 | The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research. (Radtke HB, Klein-Tasman BP, Merker VL, Knight P, Ullrich NJ, Jordan JT, Korf B, Plotkin SR) Orphanet J Rare Dis 2021 Feb 01;16(1):61 18 Citations |
| 1 | Congenital anomalies and vascular birthmarks of the lower extremities. (Laor T, Burrows PE) Magn Reson Imaging Clin N Am 1998 Aug;6(3):497-519 45 Citations |
| 1 | Philadelphia chromosome-positive chronic myeloid leukemia and thoracic ganglioneuroma. Previously undescribed association. (Shea MP, Abshire TC) Am J Pediatr Hematol Oncol 1993 Feb;15(1):111-4 3 Citations |
